Burkitt’s lymphoma is a fast-growing cancer of the lymphatic system.
While it is relatively rare in adults, it is one of the common cancers in children. The chances of cure are high – yet only twenty percent of children who suffer a relapse survive.
With a donation of 40.000 €, BIOMEX is supporting the excellent work of two university groups investigating on Burkitt’s lymphoma in children:
Prof. Dr. Dr. Birgit Burkhardt’s group from Münster University Hospital (#UKM) is trying to understand the genetic mechanisms in the cells that underlie the relapse of affected children.
The group of Prof. Dr. Wilhelm Wößmann from the University Medical Center Hamburg-Eppendorf (UKE) is establishing methods to help identify children at risk of relapse at an early stage.
We are very pleased to be able to contribute to a better understanding of this disease with our donation and wish the two research groups every success with their projects.
Learn more about the projects here.